| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |